Predicting and detecting cardiac allograft rejection

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/74 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2233724

This invention is directed to a method of diagnosing cardiac transplant rejection within a patient comprising, obtaining a sample of a biological fluid from said patient, and determining the level of a brain natriuretic peptide (BNP) or a fragment thereof, within said sample of body fluid. The step of determining the concentration of BNP involves an assay comprising at least one antibody exhibiting affinity for said BNP or a fragment thereof, and the biological fluid comprises plasma, urine or cerebrospinal fluid. Furthermore, the antibody used within the method may comprises a polyclonal antibody, a monoclonal antibody, or a combination thereof. Preferably, the method involves obtaining at least two said samples of body fluid from said patient over a period of time and comparing the BNP levels, with an increase in BNP being indicative of an upcoming rejection episode.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Predicting and detecting cardiac allograft rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Predicting and detecting cardiac allograft rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predicting and detecting cardiac allograft rejection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1852610

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.